Beijing, Beijing, China | Fund Name | Location |
| Ashoka | Arlington, United States, Virginia |
| Avatech | Iran, Tehran, Tehran County |
| Bohai Zhongsheng | China, Hubei, Wuchang |
| Cantor Fitzgerald | New York, New York, United States |
| Ewert Leaf Labs | Australia, South Melbourne, Victoria |
| Fame Mount Limited | - |
| Fuhai Yintao | China, Guangdong, Shenzhen |
| Great Culture Capital Management | China, Pudong, Shandong |
| Jiaxing Pucheng Gquan Touzi Hehuoqiye | China, Jiaxing, Zhejiang |
| Kingson Capital Partners | Durban, KwaZulu-Natal, South Africa |
| Novelion Therapeutics | British Columbia, Canada, Vancouver |
| Ooredoo Group | Ad Dawhah, Doha, Qatar |
| Savitr Capital | California, San Francisco, United States |
| Shui On Development | China, Shanghai |
| Valquest Partners | Beirut, Beyrouth, Lebanon |
| Viva BioInnovator | China, Shanghai |
| Zain Group | Al Kuwayt, Kuwait, Safat |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $14M | 22 Apr 2020 | Jiangsu | |||
CapitalBio Technology | $3M | 18 Dec 2017 | Dongcheng District, Beijing, China | ||
BlueStar | $13M | 20 Aug 2016 | Haidian, Beijing, China | ||
TRACEBoard | $3M | 16 Sep 2015 | Haidian, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $14M | 22 Apr 2020 | Jiangsu | |||
CapitalBio Technology | $3M | 18 Dec 2017 | Dongcheng District, Beijing, China | ||
BlueStar | $13M | 20 Aug 2016 | Haidian, Beijing, China | ||
TRACEBoard | $3M | 16 Sep 2015 | Haidian, Beijing, China |
